The HAM Infliximab Study

Stopped Higher toxicity rate than observed in studies in Rheumatoid arthritis

Conditions

• HTLV-I-associated Myelopathy

Interventions

• DRUG: Infliximab

Sponsor

Imperial College London

Collaborators

• [object Object]